Court Awards 'Unprecedented' $6M in Attorneys’ Fees
Posted in Attorney Fees, Lodestar
In a Nexium class action against AstraZeneca Pharmaceuticals, Justice Sanders awarded $6 million in attorneys’ fees—30% of the $20 million common fund agreed to in a settlement achieved shortly before trial. Justice Sanders acknowledged that this was an “unprecedented” award for state court, but believed it was warranted by the facts of this case.
Commonwealth Care Alliance and Crenshaw v. Astrazeneca Pharmaceuticals, L.P.
Full decision here.
PartnerEric Magnuson litigates high-stakes commercial disputes in state and federal courts. He tries cases, argues appeals, and leads dispositive strategy. His practice includes class-action defense, business and fiduciary ...
RSS FeedBlog Editors
Senior Editor, Co-Chair, Business Litigation Practice Group
Partner